Saniona AB (CHIX:SANIOS) Marketable Securities: kr0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SANIOS Saniona AB CHIX:SANIOS
65 GF Score
Price kr12.75
GF Value kr25.78
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Marketable Securities?

Saniona AB CHIX:SANIOS 65 Marketable Securities is kr0.0 Mil as of Mar. 2026. GuruFocus rates CHIX:SANIOS with a GF Score™ of 65/100 and a GF Value™ of kr25.78 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Saniona AB's Marketable Securities for the quarter that ended in Mar. 2026 was kr0.0 Mil.

Saniona AB  (CHIX:SANIOs) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Saniona AB Marketable Securities Related Terms

Saniona AB Marketable Securities Historical Data

* Premium members only.

The historical data trend for Saniona AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB Marketable Securities Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:SANIOS
65GF Score
Saniona AB CHIX:SANIOS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of kr0.0 Mil mean?
Saniona AB (CHIX:SANIOS) has a Marketable Securities of kr0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Saniona AB and its competitors.
Is Saniona AB's Marketable Securities too high?
Saniona AB's current Marketable Securities is kr0.0 Mil. Overall, Saniona AB has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's Marketable Securities compare to VRTX and REGN?
Saniona AB's Marketable Securities of kr0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Saniona AB and its competitors. Saniona AB's current Marketable Securities is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (CHIX:SANIOS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr25.78, compared to a current price of kr12.75 — trading 50.5% below its estimated fair value. The current Marketable Securities is kr0.0 Mil. Saniona AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Saniona AB (CHIX:SANIOS), the current Marketable Securities is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (CHIX:SANIOS) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of kr12.75 is trading 50.5% below its estimated GF Value™ of kr25.78. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for CHIX:SANIOS:

  • Marketable Securities: kr0.0 Mil
  • GF Value™: kr25.78 vs. price of kr12.75 (50.5% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the CHIX:SANIOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
65GF Score

Get the complete analysis for CHIX:SANIOS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.75
Price
kr25.78
GF Value